Argent BioPharma (RGT) Competitors GBX 5.68 -0.82 (-12.62%) (As of 12/20/2024 12:06 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors RGT vs. CHLL, MXC, N4P, HELD, HLN, HIK, HCM, INDV, AMYT, and AGYShould you be buying Argent BioPharma stock or one of its competitors? The main competitors of Argent BioPharma include Chill Brands Group (CHLL), Argent BioPharma (MXC), N4 Pharma (N4P), Hellenic Dynamics (HELD), Haleon (HLN), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), and Allergy Therapeutics (AGY). These companies are all part of the "drug manufacturers - specialty & generic" industry. Argent BioPharma vs. Chill Brands Group Argent BioPharma N4 Pharma Hellenic Dynamics Haleon Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Allergy Therapeutics Chill Brands Group (LON:CHLL) and Argent BioPharma (LON:RGT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, analyst recommendations, risk and dividends. Does the MarketBeat Community prefer CHLL or RGT? Chill Brands Group received 6 more outperform votes than Argent BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformChill Brands GroupOutperform Votes666.67% Underperform Votes333.33% Argent BioPharmaN/AN/A Do insiders & institutionals have more ownership in CHLL or RGT? 0.2% of Chill Brands Group shares are owned by institutional investors. Comparatively, 1.1% of Argent BioPharma shares are owned by institutional investors. 24.2% of Chill Brands Group shares are owned by insiders. Comparatively, 17.8% of Argent BioPharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to CHLL or RGT? In the previous week, Chill Brands Group had 2 more articles in the media than Argent BioPharma. MarketBeat recorded 2 mentions for Chill Brands Group and 0 mentions for Argent BioPharma. Argent BioPharma's average media sentiment score of 0.00 beat Chill Brands Group's score of -0.02 indicating that Argent BioPharma is being referred to more favorably in the news media. Company Overall Sentiment Chill Brands Group Neutral Argent BioPharma Neutral Which has better earnings & valuation, CHLL or RGT? Chill Brands Group has higher revenue and earnings than Argent BioPharma. Argent BioPharma is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChill Brands Group£624.19K0.00-£3.64M-£0.01N/AArgent BioPharmaN/AN/A-£17.53M-£0.24-23.67 Is CHLL or RGT more profitable? Argent BioPharma's return on equity of 0.00% beat Chill Brands Group's return on equity.Company Net Margins Return on Equity Return on Assets Chill Brands GroupN/A -2,802.21% -44.64% Argent BioPharma N/A N/A -108.57% Which has more risk & volatility, CHLL or RGT? Chill Brands Group has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, Argent BioPharma has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. SummaryChill Brands Group beats Argent BioPharma on 7 of the 12 factors compared between the two stocks. Ad Stansberry Research2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisisDan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. Get Argent BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RGT vs. The Competition Export to ExcelMetricArgent BioPharmaDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£3.05M£1.17B£5.14B£1.92BDividend YieldN/A3.04%5.09%5.45%P/E Ratio-23.67131.2389.971,880.82Price / SalesN/A1,981.001,116.34397,035.90Price / CashN/A10.2543.1028.78Price / Book-0.523.084.782.81Net Income-£17.53M£152.21M£120.31M£156.11M7 Day Performance-18.86%-0.48%-1.92%-2.03%1 Month Performance-64.50%-1.88%13.65%21.85%1 Year PerformanceN/A98.32%28.34%30.10% Argent BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RGTArgent BioPharmaN/AGBX 5.68-12.6%N/AN/A£3.05MN/A-23.67N/AGap DownCHLLChill Brands GroupN/AGBX 2.15flatN/AN/A£10.89M£624,187.00-215.007News CoverageMXCArgent BioPharmaN/AGBX 22+4.8%N/AN/A£9.65M£1.32M-13.255Gap UpN4PN4 PharmaN/AGBX 0.55-8.3%N/A-38.9%£2.17M£23,524.00-55.005Gap UpHELDHellenic DynamicsN/AGBX 0.95flatN/AN/A£1.40MN/A0.00N/AHLNHaleon0.6447 of 5 starsGBX 381.12+0.1%GBX 415+8.9%+18.8%£34.45B£11.26B3,176.0025,408High Trading VolumeHIKHikma Pharmaceuticals1.5471 of 5 starsGBX 1,915-1.2%GBX 2,383.33+24.5%+9.2%£4.25B£3.02B2,946.159,100News CoverageHCMHUTCHMEDN/AGBX 244+2.1%N/A-11.7%£2.08B£610.81M-6,100.001,760INDVIndivior2.4989 of 5 starsGBX 931-2.0%GBX 1,650+77.2%-21.9%£1.20B£1.15B-1,155.411,000Analyst ForecastAMYTAmryt PharmaN/AGBX 143-11.7%N/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 6.40flatN/A+220.0%£305.28M£53.26M-106.67612 Related Companies and Tools Related Companies Chill Brands Group Alternatives Argent BioPharma Alternatives N4 Pharma Alternatives Hellenic Dynamics Alternatives Haleon Alternatives Hikma Pharmaceuticals Alternatives HUTCHMED Alternatives Indivior Alternatives Amryt Pharma Alternatives Allergy Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:RGT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Argent BioPharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Argent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RGT Stock Alerts